Press release
Klebsiella Pneumoniae Infections Therapeutics Market Size in the 7MM is expected to Grow by 2034, estimates DelveInsight
Unlock key insights into the Klebsiella Pneumoniae Infections Market! Download DelveInsight's comprehensive report to explore market trends, pipeline analysis, and emerging therapies @ Klebsiella Pneumoniae Infections Market Size [https://www.delveinsight.com/sample-request/klebsiella-pneumoniae-infections-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Klebsiella Pneumoniae Infections Market Report
* In the United States, Klebsiella pneumoniae is responsible for most human illnesses. Many Klebsiella infections are acquired in the hospital setting or in long-term care facilities. In fact, Klebsiellae account for up to 8% of all hospital-acquired infections.
* K. pneumonia is considered the most common cause of hospital-acquired pneumonia in the US, and the organism accounts for 3% to 8% of all nosocomial bacterial infections.
* The prevalence of Klebsiella pneumonia was reported to be 24% in adults admitted to intensive care units in healthcare settings in France.
* K. pneumoniae accounts for approximately 11.8% of all hospital-acquired pneumonia globally.
* Approximately 8% to 12% of pneumonia cases occur in individuals on ventilators, often attributed to Klebsiella pneumoniae. Contrastingly, only 7% of pneumonia instances arise in patients who are not ventilated.
* The leading Klebsiella Pneumoniae Infections Companies such as Iterum Therapeutics, LimmaTech Biologics/ GSK , and others.
* Promising Klebsiella Pneumoniae Infections Therapies such as ORLYNVAH (sulopenem etzadroxil and probenecid), Kleb4V, Tigecycline, and others.
Stay ahead in the competitive landscape of the Klebsiella Pneumoniae Infections Market. Access DelveInsight's in-depth market analysis and strategic insights today! Click here for more @ Klebsiella Pneumoniae Infections Treatment Market Size [https://www.delveinsight.com/sample-request/klebsiella-pneumoniae-infections-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Klebsiella Pneumoniae Infections Epidemiology Segmentation in the 7MM
* Klebsiella Pneumoniae Infections Type-specific Diagnosed Prevalent Cases
* Total Klebsiella Pneumoniae Infections Diagnosed Prevalent Cases
* Klebsiella Pneumoniae Infections Treatable Cases
Download the report to understand which factors are driving Klebsiella Pneumoniae Infections epidemiology trends @ Klebsiella Pneumoniae Infections Prevalence [https://www.delveinsight.com/sample-request/klebsiella-pneumoniae-infections-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Klebsiella Pneumoniae Infections Treatment Market
The treatment goal remains effective eradication of the infection while minimizing the development of antibiotic resistance, reflecting the ongoing efforts to combat this challenging pathogen. While there is no cure, supportive care, management of complications, and ongoing research aim to enhance the overall well-being of individuals living with Klebsiella Pneumoniae Infections.
Klebsiella Pneumoniae Infections Therapeutics Market
The evolving landscape of antibiotic resistance is poised to undergo significant shifts driven by the emergence of novel therapies. Promising advancements such as novel antibiotics targeting unique bacterial pathways, combination treatments to enhance efficacy, and alternative modalities like phage therapy and monoclonal antibodies offer targeted solutions crucial for combating multidrug-resistant Klebsiella pneumoniae infections and shaping future market dynamics.
Discover the future of Klebsiella Pneumoniae Infections treatments with DelveInsight's latest market report. Get expert insights and forecasts-download now! @ Klebsiella Pneumoniae Infections Market Drivers and Barriers [https://www.delveinsight.com/sample-request/klebsiella-pneumoniae-infections-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Scope of the Klebsiella Pneumoniae Infections Market Report
* Coverage- 7MM
* Study Period- 2020-2034
* Klebsiella Pneumoniae Infections Companies- Iterum Therapeutics, LimmaTech Biologics/ GSK, and others.
* Klebsiella Pneumoniae Infections Therapies- ORLYNVAH (sulopenem etzadroxil and probenecid), Kleb4V, Tigecycline, and others.
* Klebsiella Pneumoniae Infections Therapeutic Assessment: Klebsiella Pneumoniae Infections Current Marketed and Klebsiella Pneumoniae Infections Emerging Therapies
* Klebsiella Pneumoniae Infections Market Dynamics: Klebsiella Pneumoniae Infections market drivers and Parkinson's Disease market barriers
* Klebsiella Pneumoniae Infections Unmet Needs, KOL's views, Analyst's views, Klebsiella Pneumoniae Infections Market Access and Reimbursement
Explore the dynamics of the Klebsiella Pneumoniae Infections Market with DelveInsight. From market size to emerging drugs-find it all in our latest report. Read now! @ Klebsiella Pneumoniae Infections Ongoing Clinical Trials Analysis [https://www.delveinsight.com/sample-request/klebsiella-pneumoniae-infections-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Content
1. Key Insights.
2. Report Introduction.
3. Klebsiella Pneumoniae Infections Epidemiology and Market Overview at a Glance.
4. Executive Summary of Klebsiella Pneumoniae Infections.
5. Disease Background and Overview.
6. Epidemiology and Patient Population.
7. Patient Journey.
8. Klebsiella Pneumoniae Infections: Market Analysis.
9. Key Opinion Leaders' Views.
10. SWOT Analysis.
11. Unmet Needs.
12. Market Access and Reimbursement.
13. Appendix.
14. Report Methodology.
15. DelveInsight Capabilities.
16. Disclaimer
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=klebsiella-pneumoniae-infections-therapeutics-market-size-in-the-7mm-is-expected-to-grow-by-2034-estimates-delveinsight]
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/catheter-stabilization-securement-device-market
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Klebsiella Pneumoniae Infections Therapeutics Market Size in the 7MM is expected to Grow by 2034, estimates DelveInsight here
News-ID: 3823702 • Views: …
More Releases from ABNewswire
Full Body Checkup The Gateway to Proactive Health
A full body checkup is one of the most thorough and proactive approaches to taking control of your long-term health. By regularly evaluating all major bodily systems and risk factors, a full body checkup helps to identify potential problems before symptoms develop, granting you the opportunity to stay healthy and empowered. At Liv Hospital [https://int.livhospital.com/], patients benefit from advanced diagnostics, experienced specialists, and patient-centered comfort throughout the process, making routine…
Andy DeFrancesco on Market Cycles, Business Mindset, and the Future of the Busin …
Image: https://www.abnewswire.com/upload/2025/11/d35dbae4dbd114c90cd75748c7d93c3c.jpg
Market optimism rises and falls in waves, but the people who shape industries rarely move with emotion. They study patterns, look beyond the noise, and respond to momentum before the crowd recognizes it. Andy DeFrancesco [https://www.linkedin.com/authwall?trk=bf&trkInfo=AQGgt6lQ4W3QHgAAAZqcxvlI_dUN8oxVB90MzEZ8iE-RruFwmtW1mgWieTjNpqt9TfGmpIboUWLMgp2cCS3U44ppQA-fyWs0h6Op-uvqdNuDq7e6HJhMneocPYkXhKrOLhPDFUM=&original_referer=&sessionRedirect=https%3A%2F%2Fwww.linkedin.com%2Fin%2Fandy-defrancesco-77584930a] has spent his entire career doing exactly that. After decades in public markets, private equity, and emerging sectors, he has learned that the numbers matter - but the psychology behind them matters more.
Business…
The Current Business Landscape: A High-Stakes, Tech-Driven Era
In 2025, the global business environment is shaped by a complex interplay of technology, economic pressures, and evolving market expectations. While inflation and cost control remain real concerns for many companies, digital transformation and cyber risk are dominating boardroom conversations. Business leaders increasingly cite artificial intelligence, cybersecurity, and cost management as their top priorities.
At the same time, the pace of technology adoption continues to accelerate. Small and midsize businesses are…
Contrarian Watch Company Launches Swiss-Made Luxury Timepieces for Those Who Dar …
Contrarian Watch Company debuts with a mission to redefine accessible luxury through Swiss-made timepieces that blend precision craftsmanship with bold design. The collection targets individuals who refuse to follow trends, offering top-quality watches that make statements this holiday season and beyond.
As holiday shopping season begins and consumers seek meaningful gifts that convey sophistication and thought, a new player in the luxury watch market is challenging industry conventions. Contrarian Watch Company…
More Releases for Klebsiella
Klebsiella Pneumoniae Infections Market is projected to reach USD 5.0 billion by …
Klebsiella pneumoniae is a Gram-negative bacterium responsible for a wide range of healthcare- and community-acquired infections, including pneumonia, bloodstream infections, urinary tract infections (UTIs), and liver abscesses. It is a major concern in intensive care units (ICUs) and among immunocompromised patients.
The growing global burden of antimicrobial resistance (AMR) has made Klebsiella pneumoniae one of the most dangerous pathogens, particularly strains resistant to carbapenems, cephalosporins, and aminoglycosides. The World Health Organization…
Klebsiella Testing Market Growth Analysis Report 2022 to 2030 | CAGR 7.1%
𝗧𝗵𝗲 𝗚𝗹𝗼𝗯𝗮𝗹 𝗞𝗹𝗲𝗯𝘀𝗶𝗲𝗹𝗹𝗮 𝗧𝗲𝘀𝘁𝗶𝗻𝗴 𝗠𝗮𝗿𝗸𝗲𝘁 𝗜𝘀 𝗘𝘅𝗽𝗲𝗰𝘁𝗲𝗱 𝗧𝗼 𝗚𝗿𝗼𝘄 𝗔𝘁 𝗔 𝗖𝗔𝗚𝗥 𝗢𝗳 7.1% 𝗗𝘂𝗿𝗶𝗻𝗴 𝗧𝗵𝗲 𝗙𝗼𝗿𝗲𝗰𝗮𝘀𝘁 𝗣𝗲𝗿𝗶𝗼𝗱.
𝗞𝗹𝗲𝗯𝘀𝗶𝗲𝗹𝗹𝗮 𝗧𝗲𝘀𝘁𝗶𝗻𝗴 𝗠𝗮𝗿𝗸𝗲𝘁 𝗢𝘃𝗲𝗿𝘃𝗶𝗲𝘄:
Global Klebsiella Testing Market 2022-2030, report discovers comprehensive insights on key manufacturers with share information, market size and projection, key dynamics, growth factors, and new company profiles. The report provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth in the coming…
Klebsiella Infections Therapeutics- Pipeline Analysis 2018, Clinical Trials & Re …
Klebsiella infections include different types of infections like bloodstream infections; pneumonia; wound or surgical site infections; and meningitis, caused by the Klebsiella bacteria. The symptoms associated with these infections are high fevers, chills, cough, and shortness of breath.
Download the sample report @ https://www.pharmaproff.com/request-sample/1065
Hospitalized patients undergoing treatment for other conditions may be susceptible to these infections. In healthcare settings, patients who require long courses of antibiotics, or are treated with…
Klebsiella Pneumoniae Infections Market Symptoms, Consulting Services, Epidemiol …
Klebsiella Pneumoniae Infections Market Epidemiology outlays comprehensive Insight of the disease, historical & forecasted epidemiology as well as the market trends of Klebsiella Pneumoniae Infections Industry. The Report provides a detailed picture of the current treatment practices, emerging drugs, a market share of the individual therapies, current and forecasted market size of Klebsiella Pneumoniae Infections.
The Klebsiella Pneumoniae Infections Market Report also covers current treatment practice/algorithm, market drivers, market barriers and…
Klebsiella pneumoniae Infections Market : Potential and Niche Segments, Geograph …
ReportBazzar has released its latest research-based report entitled ‘Klebsiella pneumoniae Infections’ market.
This report provides a holistic approach to the market growth with a detailed and precise analysis of the overall competitive scenario of the Klebsiella pneumoniae Infections market. The report also provides a detailed analysis of key trends and latest technologies, playing a prominent role in the Klebsiella pneumoniae Infections market growth. It takes into account aspects such as drivers,…
Klebsiella pneumoniae Infections (Infectious Disease) Pipeline Forecast Report, …
Market Research Hub's latest Pharmaceutical and Healthcare disease pipeline guide Klebsiella pneumoniae Infections - Pipeline Review, H1 2017, provides an overview of the Klebsiella pneumoniae Infections (Infectious Disease) pipeline landscape. Klebsiella pneumoniae is a Gram-negative bacteria. A Klebsiella pneumoniae infection is caused when the organism is able to enter the lungs. A Klebsiella pneumoniae infection is very common in patients with underlying diseases like diabetes, chronic lung diseases and chronic…
